Microenvironmental determinants of organized iPSC-cardiomyocyte tissues on synthetic fibrous matrices.


Journal

Biomaterials science
ISSN: 2047-4849
Titre abrégé: Biomater Sci
Pays: England
ID NLM: 101593571

Informations de publication

Date de publication:
05 Jan 2021
Historique:
pubmed: 17 12 2020
medline: 15 5 2021
entrez: 16 12 2020
Statut: ppublish

Résumé

Cardiomyocytes derived from induced pluripotent stem cells (iPSC-CMs) show great potential for engineering myocardium to study cardiac disease and create regenerative therapies. However, iPSC-CMs typically possess a late embryonic stage phenotype, with cells failing to exhibit markers of mature adult tissue. This is due in part to insufficient knowledge and control of microenvironmental cues required to facilitate the organization and maturation of iPSC-CMs. Here, we employed a cell-adhesive, mechanically tunable synthetic fibrous extracellular matrix (ECM) consisting of electrospun dextran vinyl sulfone (DVS) fibers and examined how biochemical, architectural, and mechanical properties of the ECM impact iPSC-CM tissue assembly and subsequent function. Exploring a multidimensional parameter space spanning cell-adhesive ligand, seeding density, fiber alignment, and stiffness, we found that fibronectin-functionalized DVS matrices composed of highly aligned fibers with low stiffness optimally promoted the organization of functional iPSC-CM tissues. Tissues generated on these matrices demonstrated improved calcium handling and increased end-to-end localization of N-cadherin as compared to micropatterned fibronectin lines or fibronectin-coated glass. Furthermore, DVS matrices supported long-term culture (45 days) of iPSC-CMs; N-cadherin end-to-end localization and connexin43 expression both increased as a function of time in culture. In sum, these findings demonstrate the importance of recapitulating the fibrous myocardial ECM in engineering structurally organized and functional iPSC-CM tissues.

Identifiants

pubmed: 33325920
doi: 10.1039/d0bm01247e
pmc: PMC7971708
mid: NIHMS1667564
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

93-107

Subventions

Organisme : NHLBI NIH HHS
ID : K08 HL130455
Pays : United States
Organisme : NIDCR NIH HHS
ID : T32 DE007057
Pays : United States

Références

Sci Adv. 2019 Oct 16;5(10):eaaw3896
pubmed: 31663014
Cell Mol Life Sci. 2014 Feb;71(4):549-74
pubmed: 23649149
Cell Stem Cell. 2020 Jun 4;26(6):862-879.e11
pubmed: 32459996
Cell Rep. 2015 Nov 24;13(8):1705-16
pubmed: 26586429
Stem Cell Reports. 2017 Nov 14;9(5):1546-1559
pubmed: 29107590
Circulation. 2009 Sep 8;120(10):876-87
pubmed: 19704095
J Cell Sci. 2019 Sep 2;132(17):
pubmed: 31391240
Sci Rep. 2016 Jan 08;6:19111
pubmed: 26743035
Cell Stem Cell. 2013 Jan 3;12(1):127-37
pubmed: 23168164
Acta Biomater. 2020 Mar 15;105:78-86
pubmed: 31945504
Nat Rev Cardiol. 2020 Jun;17(6):341-359
pubmed: 32015528
Biophys J. 2008 Oct;95(7):3479-87
pubmed: 18586852
ACS Appl Mater Interfaces. 2016 Aug 31;8(34):21923-32
pubmed: 26866596
Cell Metab. 2016 Apr 12;23(4):663-74
pubmed: 27050306
Sci Rep. 2019 Dec 2;9(1):18077
pubmed: 31792288
Proc Natl Acad Sci U S A. 2015 Oct 13;112(41):12705-10
pubmed: 26417073
Circ Arrhythm Electrophysiol. 2016 Apr;9(4):e003638
pubmed: 27069088
Am J Physiol Heart Circ Physiol. 2008 Sep;295(3):H1243-H1252
pubmed: 18641274
Stem Cells. 2015 Jul;33(7):2148-57
pubmed: 25865043
Dev Cell. 2018 Jan 8;44(1):87-96.e5
pubmed: 29316444
Biomaterials. 2001 May;22(9):943-55
pubmed: 11311013
ACS Biomater Sci Eng. 2019 Jun 10;5(6):2965-2975
pubmed: 33405599
Tissue Eng Part A. 2014 Jul;20(13-14):1896-907
pubmed: 24471778
J Biomed Mater Res A. 2010 Dec 15;95(4):1261-9
pubmed: 20939058
Stem Cell Reports. 2019 Oct 8;13(4):657-668
pubmed: 31564645
Exp Biol Med (Maywood). 2017 Nov;242(17):1643-1656
pubmed: 28343439
Tissue Eng Part C Methods. 2011 May;17(5):579-88
pubmed: 21235325
Stem Cell Res. 2016 May;16(3):740-50
pubmed: 27131761
J Cell Sci. 2008 Nov 15;121(Pt 22):3794-802
pubmed: 18957515
Nature. 2018 Apr;556(7700):239-243
pubmed: 29618819
Nanotechnology. 2015 Jul 24;26(29):291002
pubmed: 26133998
PLoS One. 2015 May 19;10(5):e0126338
pubmed: 25993466
Tissue Eng Part A. 2019 Oct;25(19-20):1426-1437
pubmed: 30727863
Nat Mater. 2015 Dec;14(12):1262-8
pubmed: 26461445
Circulation. 2020 Mar 3;141(9):e139-e596
pubmed: 31992061
J Mol Cell Cardiol. 1994 Mar;26(3):279-92
pubmed: 8028011
Biomaterials. 2014 Mar;35(9):2798-808
pubmed: 24424206
Proc Natl Acad Sci U S A. 2012 Jun 19;109(25):9881-6
pubmed: 22675119
Sci Rep. 2014 Sep 19;4:6425
pubmed: 25236849
Proc Natl Acad Sci U S A. 2013 Jun 18;110(25):10117-22
pubmed: 23733927
Birth Defects Res A Clin Mol Teratol. 2011 Jun;91(6):535-50
pubmed: 21618406
Circ Res. 1991 Mar;68(3):782-7
pubmed: 1660362
Circulation. 2020 Jan 28;141(4):285-300
pubmed: 31707831
J Biomech. 2010 Jan 5;43(1):93-8
pubmed: 19819458
Biomaterials. 2013 Sep;34(27):6355-66
pubmed: 23747008
Nat Biomed Eng. 2019 Feb;3(2):137-146
pubmed: 30911429
PLoS One. 2014 Apr 14;9(4):e94722
pubmed: 24733085
J Am Coll Cardiol. 1989 Jun;13(7):1637-52
pubmed: 2656824
Proc Natl Acad Sci U S A. 2017 Feb 21;114(8):1898-1903
pubmed: 28167795
Chemphyschem. 2004 Mar 19;5(3):383-8
pubmed: 15067875
J Mol Cell Cardiol. 2018 May;118:147-158
pubmed: 29604261
Curr Opin Biotechnol. 2013 Aug;24(4):664-71
pubmed: 23142543
Curr Protoc Hum Genet. 2018 Jan 24;96:21.11.1-21.11.20
pubmed: 29364519
Dev Cell. 2018 Feb 5;44(3):326-336.e3
pubmed: 29396114
Circulation. 2016 Nov 15;134(20):1557-1567
pubmed: 27737958
J Mol Cell Cardiol. 1995 Apr;27(4):981-90
pubmed: 7563110
Nat Mater. 2012 May 27;11(7):642-9
pubmed: 22635042
Science. 2008 Dec 12;322(5908):1687-91
pubmed: 19074349
Circ Res. 2014 Jan 31;114(3):572-586
pubmed: 24481847
Adv Healthc Mater. 2020 Apr;9(8):e1901682
pubmed: 32181987
Stem Cells Dev. 2013 Jul 15;22(14):1991-2002
pubmed: 23461462
Nat Commun. 2017 Nov 28;8(1):1825
pubmed: 29184059
Dev Biol. 2013 Sep 1;381(1):73-82
pubmed: 23791818
Biomater Sci. 2017 Jul 25;5(8):1567-1578
pubmed: 28715029
Biomaterials. 2011 Feb;32(4):1002-9
pubmed: 21071078
Sci Rep. 2019 Jan 9;9(1):12
pubmed: 30626885
Proc Natl Acad Sci U S A. 2012 Jul 3;109(27):E1848-57
pubmed: 22645348
Philos Trans R Soc Lond B Biol Sci. 2007 Aug 29;362(1484):1267-79
pubmed: 17588874

Auteurs

Samuel J DePalma (SJ)

Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI 48109, USA. bambren@umich.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH